Read here results of the IELSG38 trial conducted to investigate the effects of subcutaneous rituximab on the complete remission rate and the benefits of subcutaneous rituximab maintenance in patients with extranodal marginal zone lymphoma who received front-line treatment with chlorambucil plus rituximab. https://lnkd.in/eSyviqSX
Haematologica Journal’s Post
More Relevant Posts
-
First treatment for marginal zone lymphoma after anti-CD20-based treatment, recommended by NICE in final guidance. Zanubrutinib is a pill treatment, providing a more convenient option than current standard care. Find out more: https://lnkd.in/gYWzTRN4
To view or add a comment, sign in
-
"Early detection saves lives. Know the signs, fight lymphoma." #WorldLymphomaDay #LymphomaAwareness #CancerPrevention #EarlyDetection #FightLymphoma #CancerSupport #KnowTheSigns #LymphomaWarrior #CancerSurvivor #BeatCancer #HopeForACure #HealthAwareness #StrongTogether #FightCancer #StayInformed https://lnkd.in/grzvZGUf
To view or add a comment, sign in
-
-
How does precise diagnosis guide optimal treatment? Learn how our unique PM3CX test accurately distinguishes among multiple subtypes of large B-cell lymphoma to help inform treatment decisions. https://bit.ly/4bovrMC
To view or add a comment, sign in
-
𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐀𝐩𝐩𝐫𝐨𝐯𝐚𝐥 𝐟𝐨𝐫 𝐆𝐞𝐧𝐦𝐚𝐛'𝐬 𝐓𝐞𝐩𝐤𝐢𝐧𝐥𝐲 𝐀𝐧𝐭𝐢𝐛𝐨𝐝𝐲 🇪🇺 Genmab secures conditional European approval for Tepkinly (epcoritamab) as a monotherapy for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). 🌟 𝐊𝐞𝐲 𝐃𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧 𝐏𝐨𝐢𝐧𝐭𝐬: - How does Genmab's breakthrough for relapsed or refractory DLBCL mark a shift in the treatment landscape? - With a 62% overall response rate, how does Tepkinly revolutionize DLBCL treatment? 🔗 Explore more: https://hubs.la/Q02h9ygP0 #OGImmuno #TherapeuticModalities
European Commission Approves Genmab’s Subcutaneous Bispecific Antibody Tepkinly
To view or add a comment, sign in
-
In this nonrandomized controlled trial, response-adapted ultralow-dose therapy for indolent orbital B-cell lymphoma resulted in reduced radiation exposure, negligible toxic effects, and excellent disease outcomes. https://ja.ma/4eA6MpI
To view or add a comment, sign in
-
-
As a summary of the case, and starting from the premise of how complicated it can sometimes be to reach a diagnosis solely based on iconography, we want to highlight how grouping the different clinical signs can help us make a differential diagnosis in this case between retinitis or infiltration by a lymphoma. We hope this serves you in your daily clinical practice!
To view or add a comment, sign in
-
At #ASH23, updates from four key studies evaluating the efficacy and safety of CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma were presented. Read more here 👉 https://loom.ly/OduvUyQ #lymsm #lymphoma
To view or add a comment, sign in
-
-
World Lymphoma Awareness Day🌍👤 Lymph Nodes are your body's silent heroes, They quietly stand guard, Protect heath👍 Lymphoma impacts both body and mind,👥🧠 Spot the Signs, Offer Support, awareness and empathy are key🤩 #lymphomaawarnessday #lymphoma #lymphnodes #ExpertGuidance #getnutrition #DietitianConsultation #customizedcareplan #therapeuticdietplan #carecoordinator #postoperativecare #aiindigitalhealth #healthpackage #QuickRecovery #qurbook QurHealth
To view or add a comment, sign in
-
-
Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells https://lnkd.in/gDT--KjC
To view or add a comment, sign in
-
Lymphoma may be silent, but awareness speaks volumes and understanding Lymphoma is the first step to fighting it ! This Lymphoma Awareness Day, let’s learn the signs, act early, and empower your health for a brighter future. #lymphoma #lymphomaawareness #lymphomacancer #lymphomawarrior #lymphomasurvivor #lymphomasurvivor #LymphomaTreatment #SUMUM
To view or add a comment, sign in
-